Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs
- 24 April 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Human Hypertension
- Vol. 16 (S2), S24-S28
- https://doi.org/10.1038/sj.jhh.1001395
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The new oral angiotensin II antagonist olmesartan medoxomil: a concise overviewJournal of Human Hypertension, 2002
- Comparative antihypertensive efficacy of olmesartan: comparison with other angiotensin II receptor antagonistsJournal of Human Hypertension, 2002
- Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential HypertensionThe Journal of Clinical Hypertension, 2001
- The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interactionJournal Of Hypertension, 2001
- Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonistJournal Of Hypertension, 2001
- Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensivesJournal Of Hypertension, 2001
- How do angiotensin II receptor antagonists affect blood pressure?The American Journal of Cardiology, 1999
- Comparative Safety and Tolerability of Angiotensin II Receptor AntagonistsDrug Safety, 1999
- Angiotensin II antagonists lead the way in hypertension managementInpharma Weekly, 1998
- Blood Pressure and Mortality Among Men With Prior Myocardial InfarctionCirculation, 1995